Document is current
Any future updates will be listed below
-
Authors
Thran, Moritz
Mukherjee, Jean
Pönisch, Marion
Fiedler, Katja
Thess, Andreas
Mui, Barbara L
Hope, Michael J
Tam, Ying K
Horscroft, Nigel
Heidenreich, Regina
Fotin‐Mleczek, Mariola
Shoemaker, Charles B
Schlake, Thomas https://orcid.org/0000-0001-6292-4055
- License Information
-
More Information
Article History
Received: 15 February 2017
Revised: 12 July 2017
Accepted: 13 July 2017
First Online: 9 August 2017
Conflict of interest
: MT, MP, AT, KF, NH, RH, MF‐M, and TS are employees of CureVac AG developing therapeutics based on sequence‐engineered mRNA. BLM, MJH, and YKT are employees of Acuitas Therapeutics, a company providing delivery solutions for molecular therapeutics using lipid nanoparticles.
